Healthcare provider profile · identity verified

Thomas H Bugbee, MD

Family Practice · BLUE HILL, ME · NPI 1326082405

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	273	70
Levothyroxine Sodium	Levothyroxine Sodium	206	43
Amlodipine Besylate	Amlodipine Besylate	187	51
Losartan Potassium	Losartan Potassium	185	37
Lisinopril	Lisinopril	173	45
Omeprazole	Omeprazole	115	26
Hydrochlorothiazide	Hydrochlorothiazide	98	21
Metoprolol Tartrate	Metoprolol Tartrate	94	22
Gabapentin	Gabapentin	93	23
Metoprolol Succinate	Metoprolol Succinate	91	24
Metformin Hcl	Metformin Hcl	86	23
Pantoprazole Sodium	Pantoprazole Sodium	82	25
Lorazepam	Lorazepam	79	19
Albuterol Sulfate Hfa	Albuterol Sulfate	76	23
Rosuvastatin Calcium	Rosuvastatin Calcium	71	18
Potassium Chloride	Potassium Chloride	67	12
Trazodone Hcl	Trazodone Hcl	67	11
Jardiance	Empagliflozin	60	11
Prednisone	Prednisone	59	25
Tamsulosin Hcl	Tamsulosin Hcl	59	16
Duloxetine Hcl	Duloxetine Hcl	56	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	55	suppressed
Famotidine	Famotidine	52	13
Eliquis	Apixaban	51	14
Tramadol Hcl	Tramadol Hcl	49	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	14
Simvastatin	Simvastatin	47	12
Escitalopram Oxalate	Escitalopram Oxalate	45	11
Chlorthalidone	Chlorthalidone	44	12
Trulicity	Dulaglutide	44	suppressed
Donepezil Hcl	Donepezil Hcl	40	suppressed
Furosemide	Furosemide	40	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	17
Metformin Hcl Er	Metformin Hcl	38	suppressed
Alprazolam	Alprazolam	37	11
Ezetimibe	Ezetimibe	37	suppressed
Ozempic	Semaglutide	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Allopurinol	Allopurinol	36	suppressed
Carvedilol	Carvedilol	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Azithromycin	Azithromycin	34	25
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	11
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Clonazepam	Clonazepam	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Celecoxib	Celecoxib	25	suppressed
Nystatin	Nystatin	25	17
Farxiga	Dapagliflozin Propanediol	24	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Fentanyl	Fentanyl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	18
Diazepam	Diazepam	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Oxcarbazepine	Oxcarbazepine	19	suppressed
Risperidone	Risperidone	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	18
Estradiol	Estradiol	18	suppressed
Cephalexin	Cephalexin	17	11
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Topiramate	Topiramate	16	suppressed
Baclofen	Baclofen	15	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	13
Bupropion Xl	Bupropion Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Sertraline Hcl	Sertraline Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Valsartan	Valsartan	13	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	13	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Finasteride	Finasteride	12	suppressed
Glipizide	Glipizide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error